What is ReAlta Life Sciences worth?
$230.0Mlast known valuation
ReAlta Life Sciences last raised $25.0M in its Early Stage VC (Dec 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for ReAlta Life Sciences
Create free account
No card required
Funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2024 | Early Stage VC | $25.0M | ▮ | ▮ |
| Nov 2023 | Early Stage VC | $29.9M | ▮ | ▮ |
| Feb 2023 | Early Stage VC | $12.0M | ▮ | ▮ |
| Dec 2020 | Early Stage VC | $22.5M | ▮ | ▮ |
| Sep 2018 | Seed Round | $4.8M | ▮ | ▮ |
How ReAlta Life Sciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For ReAlta Life Sciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is ReAlta Life Sciences worth?
- ReAlta Life Sciences's last known valuation is $230.0M.
- How much has ReAlta Life Sciences raised?
- ReAlta Life Sciences has raised $155.4M in total funding across 5 recorded rounds.
- When did ReAlta Life Sciences last raise?
- ReAlta Life Sciences last raised in Dec 2024 (Early Stage VC), raising $25.0M.